Cumulus Oncology

We are happy to announce our attendance at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place from 23rd - 25th October 2024 at the CCIB in Barcelona, Spain!   This prestigious event brings together leading experts in oncology and cancer research, offering a unique platform to explore the latest advancements in molecular targets and innovative cancer therapies. Our CEO & Founder, Clare Wareing, together with Executives in Residence, Tilly (Matilda) Bingham (GIO Therapeutics) and Dominic James PhD, FRSB (Nodus Oncology) will be in attendance. We look forward to connecting with industry leaders, researchers, and fellow professionals to exchange insights and collaborate on the future of cancer treatment. If you’re attending, let’s connect!    #EORTCNCIAACR2024 #CancerResearch #Oncology #MolecularTargets #CancerTherapeutics #BarcelonaEvents  

We are delighted to announce that our Founder and CEO, Clare Wareing, will be attending the Fierce Biotech Summit in Boston, MA, on September 30th - October 1st!   As a recognized leader in biotech innovation, Clare is looking forward to engaging with industry experts, sharing insights on the latest breakthroughs, and exploring exciting new collaborations. The summit will bring together thought leaders driving the future of healthcare and biotechnology - don’t miss this opportunity to connect!   If you're attending the event, we’d love to connect! Let us know if you’ll be there too.   #Biotech #Innovation #FierceBiotech #Leadership #Healthcare

Delighted to announce we will be attending Endpoints 11 Gala Dinner at the prestigious State Room in Boston, MA on the 26th of September! This is a premier event that brings together leading minds in the industry, and we’re excited to be a part of it.   Our CEO & Founder, Clare Wareing, will be in attendance and is looking forward to a dynamic evening celebrating the success of a wide range of people and organisations is the global biotech community.    If you’ll be there, Clare would welcome the opportunity to connect, share ideas, and discuss opportunities!   Looking forward to seeing many of you at the event. Don’t hesitate to reach out if you’d like to arrange a time to meet up during the day! #Endpoints11 #GalaDinner #Networking #Leadership #Innovation #LifeSciences #Biotech #BusinessDevelopment

We are attending the SACHS – 24th Annual Biotech in Europe Forum on the 25th - 26th of September.   Our Business Development and Investment Director, Laurent Jacqueroud, will be speaking on an insightful panel discussion alongside other industry experts. Don’t miss the chance to hear about the latest innovations and investment opportunities in the biotech sector!   We look forward to connecting with you there!   #Biotech #Investment #Innovation #Networking #SACHSBiotech #EuropeForum

We’re excited to share that our Business Development & Investment Director, Laurent Jacqueroud, will be representing Cumulus Oncology at the Impart Summit 2024 on the 16th – 18th September in Lyon, France.   Laurent will also be part of a panel discussion, sharing insights on the future of oncology innovation and investment.   Don't miss this opportunity to connect and learn from industry leaders!   #ImpartSummit2024 #CumulusOncology #OncologyInnovation #PanelDiscussion #LyonSummit2024

📢 Cumulus Oncology is excited to participate in RESI Boston 2024. Join us at The Westin Copley Place on September 25th to connect with our Founder and CEO, Clare Wareing. Discover how Cumulus Oncology is reshaping the biotech model. Schedule a meeting today by scanning the QR code below! We welcome the opportunity to discuss the future of healthcare together. #RESIBoston #LifeSciences #CumulusOncology #Networking #BiotechInnovation

We're thrilled to see Nodus Oncology join forces with Lead Discovery Center GmbH!  This collaboration is a fantastic example of how teamwork can drive innovation and bring new value to our industry.   Check out their original post to learn more about this exciting partnership!   #Collaboration #Innovation #Partnerships

Cumulus Oncology is attending the ELRIG UK Drug Discovery Scotland Forum, at the Royal College of Physicians, Edinburgh, on the 12th September 2024.  Our Senior Operations Lead, Laura Gallagher, will be attending and is eager to connect with you during the event. If you're also attending, please don't hesitate to get in touch!   #ELRIGUK #DrugDiscovery #EdinburghScotland #LifeScience #Networking 

Cumulus Oncology is attending the LSX World Congress, at the Hynes Convention Centre, Boston, MA, on the 11th – 12th September 2024.  Our Chief Business Officer, Tim Sparey, will be attending and is eager to connect with you during the event. If you're also attending, please don't hesitate to get in touch!   #LSXWorldCongress #Innovators #Healthtech #Biotech #Networking 

Our CEO Clare Wareing sat down with Nuala Moran to discuss the latest developments at Cumulus Oncology! Read the article from BioWorld below 👇   As we look to raise a $50M series A round, our strategic model of translating novel discoveries from a range of sources including academia and drug discovery groups into drug development programs and startups is gaining momentum.   We’ve launched our second spinout, GIO Therapeutics as part of an ongoing successful collaboration with leadXpro AG to identify small molecules targeting the critical GPR68 receptor for therapeutic intervention in oncology and inflammation. Our platform and modality agnostic approach coupled with our data driven process at the Cumulus level (the hub) enables effective decision making to accelerate and prioritise only those programmes which have the highest chance of being successful therapeutics.   The model not only enhances the capital efficiency of drug discovery but also sets a new standard for how we advance innovative therapies.   🥼About Cumulus Oncology: https://lnkd.in/en9se3Cq   #Biotech #Pharma #Oncology #Cancer #Innovation Clarivate for Life Sciences & Healthcare, Taylor Wessing UK